{
    "medicine_id": "631f8c969c5a39e990acbb84369b1b0a4026dd0b",
    "platform_id": "DB00922",
    "metadata": {
        "name": "Act Buprenorphine naloxone 35 Mikrogramm h Plaster",
        "composition": "35 Mikrogramm h Levosimendan",
        "clinical_particulars": {
            "therapeutic_indications": "For short term treatment of acutely decompensated severe chronic heart failure CHF Also being investigated for use treatment in heart disease",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Levosimendan is a new Ca sup 2 sup sensitizing inotropic agent Ca sup 2 sup sensitizers represent a new class of inotropic agents which overcome the disadvantages associated with currently available inotropic agents in as they are not associated with an increased risk of arrhythmias cell injury and death due to Ca sup 2 sup overload in myocardial cells they do not increase the activation energy and they have the potential to reverse contractile dysfunction under pathophysiologic conditions such as acidosis or myocardial stunning Levosimendan has not been approved for use in the U S or Canada",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09083",
                        "description": "Ivabradine may increase the QTc prolonging activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of orthostatic hypotension and syncope can be increased when Levosimendan is combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of hypotension and orthostatic hypotension can be increased when Levosimendan is combined with Levodopa"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "Levosimendan may increase the hypotensive activities of Risperidone"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Nicorandil may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "Glimepiride may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "Lidocaine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "Mexiletine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "Acetyldigitoxin may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "Magnesium sulfate may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00521",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Carteolol"
                    },
                    {
                        "drugbank-id": "DB01056",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Tocainide"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Deslanoside"
                    },
                    {
                        "drugbank-id": "DB01214",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Metipranolol"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Aprindine"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Nimesulide"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Cyclandelate"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Flunarizine"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Seletracetam"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Nylidrin"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Sparteine"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Tranilast"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Fasudil"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Agmatine"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Tolfenamic acid"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Azelnidipine"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Darodipine"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Niludipine"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Tropisetron"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Carboxyamidotriazole"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Spiradoline"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Cymarin"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Metildigoxin"
                    },
                    {
                        "drugbank-id": "DB13635",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Tiracizine"
                    },
                    {
                        "drugbank-id": "DB13645",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Ethacizine"
                    },
                    {
                        "drugbank-id": "DB13718",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Hydroquinine"
                    },
                    {
                        "drugbank-id": "DB13746",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Bioallethrin"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Tertatolol"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Caroverine"
                    },
                    {
                        "drugbank-id": "DB13863",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Fosfructose"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "Levosimendan may increase the arrhythmogenic activities of WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Fish oil"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Emopamil"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Lomerizine"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB15300",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Hydroquinidine"
                    },
                    {
                        "drugbank-id": "DB15366",
                        "description": "Levosimendan may increase the arrhythmogenic activities of SOR C13"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Sotalol"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Quinidine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Procainamide"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Bepridil"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Dronedarone"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Terodiline"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "Betaxolol may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "Diltiazem may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "Nimodipine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "Cinnarizine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Propranolol may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Atropine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "Adenosine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "Loperamide may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Propafenone"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Flecainide"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Azimilide"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Eperisone"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Melperone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Benidipine"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "Esmolol may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "Pregabalin may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Isradipine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "Trimethadione may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Timolol may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Amlodipine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Digoxin may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Lamotrigine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "Ethosuximide may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "Nicardipine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "Verapamil may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "Losartan may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "Moricizine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "Levomenthol may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "Zonisamide may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "Felodipine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "Nitrendipine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "Perhexiline may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "Bretylium may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "Encainide may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "Digitoxin may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "Celiprolol may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "Methsuximide may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "Vernakalant may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "Ziconotide may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "Cariporide may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "Bupranolol may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "Indenolol may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Trimebutine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "Pinaverium may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "Aranidipine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Efonidipine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "Niguldipine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "Talinolol may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "Anisodamine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "Tetrahydropalmatine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "Pilsicainide may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Cicletanine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "Gallopamil may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "Cibenzoline may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "Bencyclane may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "Prajmaline may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "Lorajmine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "Acetyldigoxin may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "Lidoflazine may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Clevidipine"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Barnidipine"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Cilnidipine"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Atenolol"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Nisoldipine"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Alprenolol"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Nadolol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Practolol"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Dexpropranolol"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Nebivolol"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Manidipine"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Naftopidil"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Landiolol"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "Levosimendan may increase the arrhythmogenic activities of Simendan"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Amphetamine may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "Linezolid may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "Furazolidone may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "Procaine may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "Tranylcypromine may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "Phenelzine may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "Minaprine may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "Selegiline may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "Procarbazine may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "Moclobemide may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "Isocarboxazid may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "Rasagiline may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "Pargyline may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "Clorgiline may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "Iproniazid may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "Nialamide may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "Safinamide may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Methylene blue may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "Hydracarbazine may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "Pirlindole may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "Toloxatone may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "Benmoxin may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "Mebanazine may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "Octamoxin may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "Pheniprazine may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "Phenoxypropazine may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "Pivhydrazine may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "Safrazine may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "Caroxazone may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "Harmaline may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "Brofaromine may increase the orthostatic hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "Butalbital may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "Pentobarbital may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "Secobarbital may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "Methohexital may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "Thiopental may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "Primidone may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "Methylphenobarbital may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "Thiamylal may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "Phenobarbital may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "Amobarbital may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "Hexobarbital may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "Barbital may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "Barbexaclone may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "Butabarbital may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Goserelin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of QTc prolongation can be increased when Methadone is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Clozapine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Promazine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Droperidol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of QTc prolongation can be increased when Imipramine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Perflutren is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Efavirenz is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Roxithromycin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Granisetron is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxepin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of QTc prolongation can be increased when Desipramine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Flumequine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Famphur is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Fenthion is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Phosmet is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bilastine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Ebastine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 907 is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Temefos is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Givinostat is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Inotersen is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The risk or severity of adverse effects can be increased when Aldesleukin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of adverse effects can be increased when Streptokinase is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "The risk or severity of adverse effects can be increased when Ropinirole is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "The risk or severity of adverse effects can be increased when Ropivacaine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The risk or severity of adverse effects can be increased when Bupivacaine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The risk or severity of adverse effects can be increased when Tolcapone is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The risk or severity of adverse effects can be increased when Triamterene is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "The risk or severity of adverse effects can be increased when Pramipexole is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The risk or severity of adverse effects can be increased when Nabilone is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "The risk or severity of adverse effects can be increased when Amiloride is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of adverse effects can be increased when Clofarabine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The risk or severity of adverse effects can be increased when Amphotericin B is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "The risk or severity of adverse effects can be increased when Furosemide is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "The risk or severity of adverse effects can be increased when Methazolamide is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "The risk or severity of adverse effects can be increased when Tamsulosin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Sufentanil is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The risk or severity of adverse effects can be increased when Mannitol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Tretinoin is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The risk or severity of adverse effects can be increased when Conivaptan is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00883",
                        "description": "The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of adverse effects can be increased when Bumetanide is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Remifentanil is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Dipyridamole"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Levobupivacaine"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Thalidomide"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Iloprost"
                    },
                    {
                        "drugbank-id": "DB01143",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Amifostine"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Diclofenamide"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Halothane"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Paclitaxel"
                    },
                    {
                        "drugbank-id": "DB01282",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Carbetocin"
                    },
                    {
                        "drugbank-id": "DB01612",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Amyl Nitrite"
                    },
                    {
                        "drugbank-id": "DB04899",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Nesiritide"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Dapagliflozin"
                    },
                    {
                        "drugbank-id": "DB08822",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Azilsartan medoxomil"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Isoxsuprine"
                    },
                    {
                        "drugbank-id": "DB09038",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Empagliflozin"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09112",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Nitrous acid"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Arotinolol"
                    },
                    {
                        "drugbank-id": "DB09279",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Fimasartan"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Sacubitril"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Valsartan"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Ramipril"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Torasemide"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Olmesartan"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Chlorthalidone"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Nitroprusside"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Minoxidil"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Prazosin"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Fosinopril"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Metolazone"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Benazepril"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Clonidine"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Enalapril"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Mecamylamine"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Phentolamine"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Eplerenone"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Lisinopril"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Nitroglycerin"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Perindopril"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Tolazoline"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Fenoldopam"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Quinapril"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Phenoxybenzamine"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Pindolol"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Telmisartan"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Methyldopa"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Guanfacine"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Diazoxide"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Terazosin"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Captopril"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Hydralazine"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Cilazapril"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Penbutolol"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Indoramin"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Aliskiren"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Moxonidine"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Imidapril"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Riociguat"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Levosimendan may increase the hypotensive activities of Lacidipine"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Ethanol may increase the hypotensive activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Levosimendan may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "The therapeutic efficacy of Levosimendan can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Levosimendan may increase the hypotensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "Levosimendan may increase the hypotensive activities of Bethanidine"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "Levosimendan may increase the hypotensive activities of Guanadrel"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "Levosimendan may increase the hypotensive activities of Bosentan"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Levosimendan may increase the hypotensive activities of Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Levosimendan may increase the hypotensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "Levosimendan may increase the hypotensive activities of Guanabenz"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Levosimendan may increase the hypotensive activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Levosimendan may increase the hypotensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Levosimendan may increase the hypotensive activities of Tadalafil"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "Levosimendan may increase the hypotensive activities of Omapatrilat"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Levosimendan may increase the hypotensive activities of Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Levosimendan may increase the hypotensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Levosimendan may increase the hypotensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Levosimendan may increase the hypotensive activities of Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Levosimendan may increase the hypotensive activities of Guanethidine"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "Levosimendan may increase the hypotensive activities of Rescinnamine"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "Levosimendan may increase the hypotensive activities of Bevantolol"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Levosimendan may increase the hypotensive activities of Polythiazide"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "Levosimendan may increase the hypotensive activities of Saprisartan"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "Levosimendan may increase the hypotensive activities of Spirapril"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Levosimendan may increase the hypotensive activities of Tienilic acid"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "Levosimendan may increase the hypotensive activities of Debrisoquine"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "Levosimendan may increase the hypotensive activities of Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "Levosimendan may increase the hypotensive activities of Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Levosimendan may increase the hypotensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Levosimendan may increase the hypotensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Levosimendan may increase the hypotensive activities of Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "Levosimendan may increase the hypotensive activities of Temocapril"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Levosimendan may increase the hypotensive activities of Macitentan"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "Levosimendan may increase the hypotensive activities of Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "Levosimendan may increase the hypotensive activities of Trimazosin"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Levosimendan may increase the hypotensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "Levosimendan may increase the hypotensive activities of Selexipag"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Levosimendan may increase the hypotensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "Levosimendan may increase the hypotensive activities of Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Levosimendan may increase the hypotensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "Levosimendan may increase the hypotensive activities of Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "Levosimendan may increase the hypotensive activities of Urapidil"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Levosimendan may increase the hypotensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "Levosimendan may increase the hypotensive activities of Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Levosimendan may increase the hypotensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "Levosimendan may increase the hypotensive activities of Delapril"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Levosimendan may increase the hypotensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Levosimendan may increase the hypotensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Levosimendan may increase the hypotensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Levosimendan may increase the hypotensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Levosimendan may increase the hypotensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "Levosimendan may increase the hypotensive activities of Esatenolol"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Levosimendan may increase the hypotensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "Levosimendan may increase the hypotensive activities of Cloranolol"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Levosimendan may increase the hypotensive activities of Cyclopenthiazide"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Levosimendan may increase the hypotensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Levosimendan may increase the hypotensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Levosimendan may increase the hypotensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "Levosimendan may increase the hypotensive activities of Epanolol"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Levosimendan may increase the hypotensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Levosimendan may increase the hypotensive activities of Muzolimine"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Levosimendan may increase the hypotensive activities of Xipamide"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "Levosimendan may increase the hypotensive activities of Candesartan"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Levosimendan may increase the hypotensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "Levosimendan may increase the hypotensive activities of Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "Levosimendan may increase the hypotensive activities of Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "Levosimendan may increase the hypotensive activities of Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "Levosimendan may increase the hypotensive activities of Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "Levosimendan may increase the hypotensive activities of Levamlodipine"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The therapeutic efficacy of Levosimendan can be increased when used in combination with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Levosimendan may increase the QTc prolonging activities of Pitolisant"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Levosimendan may increase the vasodilatory activities of Isosorbide mononitrate"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The risk or severity of hypotension can be increased when Sildenafil is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "The risk or severity of hypotension can be increased when Milrinone is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The risk or severity of hypotension can be increased when Pentoxifylline is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of hypotension can be increased when Ibudilast is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06237",
                        "description": "The risk or severity of hypotension can be increased when Avanafil is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "The risk or severity of hypotension can be increased when Udenafil is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The risk or severity of hypotension can be increased when Doxofylline is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB11792",
                        "description": "The risk or severity of hypotension can be increased when Mirodenafil is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The risk or severity of hypotension can be increased when Fostamatinib is combined with Levosimendan"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}